Study finds ED drugs not just good in bed

Sildenafil may be joining statins and aspirin on the list of cardioprotective drugs for heart attack survivors, if findings from a Swedish study are confirmed.

The little blue pill and other PDE-5 inhibitors are associated with a 33% reduction in mortality and 40% lower risk of hospitalisation for heart failure among men who used them after having a myocardial infarction, an observational study shows.

The cardioprotective benefit should not be a surprise given that PDE-5 inhibitors such as sildenafil (Viagra) were originally